{"id":10077,"date":"2026-03-30T07:28:13","date_gmt":"2026-03-30T12:28:13","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=10077"},"modified":"2026-03-30T07:31:03","modified_gmt":"2026-03-30T12:31:03","slug":"nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u3067MCO-010\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d6\u5f97\u3001\u8996\u529b\u56de\u5fa9\u5206\u91ce\u306b\u304a\u3051\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u898f\u5236\u5bfe\u5fdc\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3092\u62e1\u5927"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"10077\" class=\"elementor elementor-10077\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6d5ad04f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6d5ad04f\" data-element_type=\"section\" data-e-type=\"section\">\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\r\n\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5bf9bdef\" data-id=\"5bf9bdef\" data-element_type=\"column\" data-e-type=\"column\">\r\n\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\r\n\t\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-e3a8c93 elementor-widget elementor-widget-text-editor\" data-id=\"e3a8c93\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span class=\"legendSpanClass\">\u30c0\u30e9\u30b9<\/span>,\u00a0<span class=\"legendSpanClass\">2026\u5e743\u670830\u65e5<\/span>\u00a0\u2014\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&l=en&o=4652030-1&h=2034434644&u=https%3A%2F%2Fprotect.checkpoint.com%2Fv2%2Fr01%2F___https%3A%2Fnanostherapeutics.com%2F___.YXAzOm5hbm9zY29wZXRoZXJhcGV1dGljczpjOm86YzI2M2YzYzU4MzM2NDk1OTA4ZWVhMzVlZThiY2RjZmM6Nzo1NDgyOjUxNzYzNjY0Zjg5MDRhZjFiYWY0M2RiMjU5YjZjNDRhZTlhYWEzNjI3YmU1NTg3NWFhYTg4ZmM4MmVjY2ViYmE6cDpUOlQ&a=Nanoscope+Therapeutics%2C+Inc.\" target=\"_blank\" rel=\"nofollow noopener\">\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e<\/a>, \u7db2\u819c\u5909\u6027\u306b\u3088\u308b\u5149\u53d7\u5bb9\u4f53\u55aa\u5931\u304a\u3088\u3073\u8996\u899a\u969c\u5bb3\u306e\u60a3\u8005\u306b\u5bfe\u3059\u308b\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u65b0\u898f\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u304a\u3088\u3073\u5546\u696d\u5316\u306b\u53d6\u308a\u7d44\u3080\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b \u306f\u672c\u65e5\u3001\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u738b\u56fd\u306b\u304a\u3044\u3066\u3001\u540c\u793e\u306e\u4e3b\u8981\u6cbb\u7642\u85ac\u3067\u3042\u308b MCO-010 \u304c\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u00a0<b>\u907a\u4f1d\u6027\u7db2\u819c\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\uff08IRD\uff09\u306b\u3088\u308b\u91cd\u5ea6\u306e\u8996\u529b\u4f4e\u4e0b\u60a3\u8005\u306e\u6cbb\u7642<\/b>.<\/p><p>\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u306e\u898f\u5236\u5f53\u5c40\u306b\u3088\u308b\u5e83\u7bc4\u306a\u6307\u5b9a\u306f\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u62e1\u5927\u3059\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u898f\u5236\u4e0a\u306e\u30d7\u30ec\u30bc\u30f3\u30b9\u3092\u3055\u3089\u306b\u5f37\u5316\u3059\u308b\u3082\u306e\u3067\u3042\u308a\u3001\u540c\u793e\u72ec\u81ea\u306e\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u753b\u671f\u7684\u306a\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3068\u306a\u308b\u53ef\u80fd\u6027\u3092\u79d8\u3081\u3066\u3044\u308b\u3053\u3068\u3092\u56fd\u969b\u7684\u306b\u8a8d\u8b58\u3057\u3064\u3064\u3042\u308b\u3053\u3068\u3092\u53cd\u6620\u3057\u3066\u3044\u308b\u3002.<\/p><p>\u201c\u300c\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3068\u3057\u3066\u306eMCO-010\u306e\u958b\u767a\u306f\u3001\u4e16\u754c\u4e2d\u306e\u898f\u5236\u5f53\u5c40\u3068\u306e\u9023\u643a\u306e\u3082\u3068\u3001\u5f15\u304d\u7d9a\u304d\u9032\u5c55\u3057\u3066\u3044\u308b\u300d\u3068\u8ff0\u3079\u305f\u3002\u00a0<b>\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005<\/b>. \u300c\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u3067\u306e\u3053\u306e\u6307\u5b9a\u306b\u3088\u308a\u3001\u79c1\u305f\u3061\u306f\u3053\u306e\u6cbb\u7642\u6cd5\u3092\u4e16\u754c\u4e2d\u306e\u60a3\u8005\u306b\u5c4a\u3051\u308b\u305f\u3081\u306e\u53d6\u308a\u7d44\u307f\u3092\u3055\u3089\u306b\u52a0\u901f\u3055\u305b\u3066\u3044\u304d\u307e\u3059\u3002\u3053\u308c\u306b\u306f\u3001\u3053\u308c\u307e\u3067\u9ad8\u5ea6\u306a\u7db2\u819c\u6cbb\u7642\u3078\u306e\u30a2\u30af\u30bb\u30b9\u304c\u9650\u3089\u308c\u3066\u3044\u305f\u5730\u57df\u3082\u542b\u307e\u308c\u307e\u3059\u3002\u300d\u201c<\/p><p><b>\u4e3b\u8981\u5e02\u5834\u5168\u4f53\u306b\u308f\u305f\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u898f\u5236\u7d4c\u8def\u306e\u69cb\u7bc9<\/b><\/p><p>\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u3067\u306e\u6307\u5b9a\u306f\u3001\u7c73\u56fd\u3001\u65e5\u672c\u3001\u6b27\u5dde\u306b\u304a\u3051\u308b\u4e00\u9023\u306e\u91cd\u8981\u306a\u898f\u5236\u4e0a\u306e\u7bc0\u76ee\u306b\u57fa\u3065\u304f\u3082\u306e\u3067\u3042\u308a\u3001MCO-010\u3092\u4e16\u754c\u3067\u6700\u3082\u958b\u767a\u4e2d\u306e\u5149\u907a\u4f1d\u5b66\u7642\u6cd5\u306e\u4e00\u3064\u3068\u3057\u3066\u4f4d\u7f6e\u3065\u3051\u308b\u3082\u306e\u3067\u3059\u3002.<\/p><p>\u7c73\u56fd\u3067\u306f\u3001MCO-010\u306f\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u5bfe\u3057\u3066\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u304a\u3088\u3073\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u308b\u307b\u304b\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u306b\u5bfe\u3057\u3066\u3082\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u3001\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u3001\u518d\u751f\u533b\u7642\u5148\u9032\u6cbb\u7642\uff08RMAT\uff09\u306e\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001Nanoscope\u793e\u306f\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u5bfe\u3059\u308b\u751f\u7269\u88fd\u5264\u627f\u8a8d\u7533\u8acb\uff08BLA\uff09\u306e\u6bb5\u968e\u7684\u306a\u63d0\u51fa\u3092\u958b\u59cb\u3057\u3066\u304a\u308a\u3001\u3053\u306e\u6cbb\u7642\u6cd5\u304c\u5f8c\u671f\u958b\u767a\u6bb5\u968e\u306b\u3042\u308b\u3053\u3068\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002.<\/p><p>\u65e5\u672c\u3067\u306f\u3001\u539a\u751f\u52b4\u50cd\u7701\u304cMCO-010\u306b\u5bfe\u3057\u3001\u5148\u99c6\u7684\u518d\u751f\u533b\u7642\u88fd\u54c1\u6307\u5b9a\u3068\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u306e\u4e21\u65b9\u3092\u4ed8\u4e0e\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306f\u3001\u7db2\u819c\u907a\u4f1d\u5b50\u6cbb\u7642\u85ac\u304c\u56fd\u5185\u3067\u3053\u308c\u307b\u3069\u5e83\u7bc4\u306a\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u305f\u521d\u3081\u3066\u306e\u4e8b\u4f8b\u3068\u306a\u308a\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u6307\u5b9a\u306b\u3088\u308a\u3001\u512a\u5148\u7684\u306a\u5354\u8b70\u3084\u5be9\u67fb\u671f\u9593\u306e\u77ed\u7e2e\u306a\u3069\u3001\u660e\u78ba\u306a\u8fc5\u901f\u627f\u8a8d\u7d4c\u8def\u304c\u78ba\u4fdd\u3055\u308c\u307e\u3059\u3002.<\/p><p>\u6b27\u5dde\u5168\u4f53\u3067\u3001MCO-010\u306f\u6b27\u5dde\u533b\u85ac\u54c1\u5e81\uff08EMA\uff09\u304b\u30895\u3064\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u304a\u308a\u3001\u5e45\u5e83\u3044\u514d\u75ab\u95a2\u9023\u75be\u60a3\uff08IRD\uff09\u3092\u5bfe\u8c61\u3068\u3057\u3001\u8907\u6570\u306e\u9069\u5fdc\u75c7\u306b\u308f\u305f\u308b\u75be\u60a3\u6a2a\u65ad\u7684\u306a\u898f\u5236\u6226\u7565\u3092\u652f\u3048\u3066\u3044\u308b\u3002.<\/p><p>\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\uff08IRD\uff09\u306f\u3001\u91cd\u5ea6\u306e\u8996\u529b\u4f4e\u4e0b\u307e\u305f\u306f\u5931\u660e\u306b\u3064\u306a\u304c\u308b\u7a00\u306a\u9032\u884c\u6027\u75be\u60a3\u7fa4\u3067\u3042\u308a\u3001\u73fe\u5728\u6709\u52b9\u306a\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u3002.\u00a0<b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306f\u3001\u5317\u7c73\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u305d\u3057\u3066\u4eca\u56de\u65b0\u305f\u306b\u4e2d\u6771\u3078\u3068\u898f\u5236\u5f53\u5c40\u3078\u306e\u7533\u8acb\u624b\u7d9a\u304d\u3092\u9032\u3081\u308b\u3053\u3068\u3067\u3001\u5149\u907a\u4f1d\u5b66\u7642\u6cd5\u306b\u304a\u3051\u308b\u6700\u3082\u5305\u62ec\u7684\u306a\u30b0\u30ed\u30fc\u30d0\u30eb\u958b\u767a\u6226\u7565\u306e\u4e00\u3064\u3092\u63a8\u9032\u3057\u3066\u3044\u307e\u3059\u3002.<\/b><\/p><p><b>MCO\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u3064\u3044\u3066<br class=\"dnr\" \/><\/b>MCO\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\uff08SD\uff09\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\uff08GA\uff09\u306a\u3069\u306e\u5149\u53d7\u5bb9\u4f53\u5909\u6027\u75c7\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u3092\u76ee\u7684\u3068\u3057\u305f\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u5358\u56de\u6295\u4e0e\u306e\u785d\u5b50\u4f53\u5185\u6cbb\u7642\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002MCO\u306f\u3001\u9ad8\u5bc6\u5ea6\u306e\u53cc\u6975\u7db2\u819c\u7d30\u80de\u3092\u6d3b\u6027\u5316\u3057\u3066\u5149\u611f\u53d7\u6027\u3092\u6301\u305f\u305b\u308b\u3053\u3068\u3067\u3001\u5149\u53d7\u5bb9\u4f53\u6b7b\u5f8c\u306b\u6b8b\u5b58\u3059\u308b\u8996\u899a\u56de\u8def\u3092\u6d3b\u7528\u3057\u307e\u3059\u3002MCO\u6cbb\u7642\u306f\u3001\u907a\u4f1d\u5b50\u691c\u67fb\u3001\u4fb5\u8972\u7684\u306a\u624b\u8853\u3001\u307e\u305f\u306f\u7e70\u308a\u8fd4\u3057\u6295\u4e0e\u3092\u5fc5\u8981\u3068\u3057\u306a\u3044\u305f\u3081\u3001\u65e2\u5b58\u306e\u7db2\u819c\u8a3a\u7642\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u5185\u3067\u5e45\u5e83\u3044\u60a3\u8005\u306b\u9069\u7528\u53ef\u80fd\u3067\u3059\u3002.<\/p><p><b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306b\u3064\u3044\u3066<br class=\"dnr\" \/><\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u6570\u767e\u4e07\u4eba\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u3001\u75be\u60a3\u3092\u554f\u308f\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04945772\" target=\"_blank\" rel=\"nofollow noopener\">NCT04945772<\/a>\uff09\u3001FDA\u3078\u306eBLA\u7533\u8acb\u306f\u7d99\u7d9a\u7684\u306b\u884c\u308f\u308c\u3066\u3044\u307e\u3059\u3002\u627f\u8a8d\u3055\u308c\u308c\u3070\u3001MCO-010\u306f\u907a\u4f1d\u5b50\u691c\u67fb\u3092\u5fc5\u8981\u3068\u305b\u305a\u3001\u8a3a\u7642\u6240\u30671\u56de\u6ce8\u5c04\u3059\u308b\u3060\u3051\u3067\u6295\u4e0e\u3067\u304d\u308b\u305f\u3081\u3001RP\u60a3\u8005\u306e\u6a19\u6e96\u6cbb\u7642\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u540c\u793e\u306f\u307e\u305f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\uff08SD\uff09\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05417126\" target=\"_blank\" rel=\"nofollow noopener\">NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/12\/nanoscope-therapeutics-announces-end-of-phase-2-meeting-with-u-s-fda-and-plan-to-initiate-a-phase-3-clinical-trial-of-mco-010-to-treat-stargardt-macular-degeneration\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u00a02026\u5e74\u306b\u958b\u59cb\u4e88\u5b9a\u3067\u3059\u3002MCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3068\u30b9\u30bf\u30d5\u30a3\u30f3\u30fb\u30c7\u30a3\u30d5\u30a3\u30b7\u30eb\u75c7\uff08SD\uff09\u306e\u4e21\u65b9\u3067FDA\u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u304a\u3088\u3073\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u304a\u308a\u3001SD\u306b\u3064\u3044\u3066\u306fRMAT\u6307\u5b9a\u3082\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u975e\u75c7\u5019\u6027\u304a\u3088\u3073\u75c7\u5019\u6027\u306e\u687f\u4f53\u30fb\u9310\u4f53\u512a\u4f4d\u6027\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u3001\u9ec4\u6591\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u3092\u5bfe\u8c61\u3068\u3059\u308bEMA\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3082\u53d7\u3051\u3066\u3044\u307e\u3059\u3002MCO-010\u306f\u3001\u65e5\u672c\u306e\u539a\u751f\u52b4\u50cd\u7701\u304b\u3089\u5148\u99c6\u533b\u85ac\u54c1\u304a\u3088\u3073\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u304a\u308a\u3001\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u738b\u56fd\u304b\u3089\u3082\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u5730\u7406\u7684\u840e\u7e2e\u75c7\uff08GA\uff09\u306b\u304a\u3051\u308bMCO\u306e\u7b2c2\u76f8\u30d7\u30ed\u30b0\u30e9\u30e0\u30822026\u5e74\u306b\u958b\u59cb\u4e88\u5b9a\u3067\u3059\u3002IND\u7533\u8acb\u6e96\u5099\u4e2d\u306e\u305d\u306e\u4ed6\u306e\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001\u30ec\u30fc\u30d0\u30fc\u5148\u5929\u6027\u9ed2\u5185\u969c\uff08LCA\uff09\u304c\u3042\u308a\u307e\u3059\u3002.<\/p><p><b>\u63a5\u89e6\uff1a<br class=\"dnr\" \/><\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e<br class=\"dnr\" \/>+1 (817) 857-1186<br class=\"dnr\" \/><a href=\"mailto:PR@nanostherapeutics.com\" target=\"_blank\" rel=\"nofollow noopener\">PR@nanostherapeutics.com<\/a>\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t<\/div>\r\n\t\t\t\t\t\t\t\t<\/div>\r\n\t\t\t<\/section>\r\n\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>DALLAS,\u00a0March 30, 2026\u00a0\u2014\u00a0Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, today announced that it has received Orphan Drug Designation in the Kingdom of Saudi Arabia for its lead therapy, MCO-010, for the\u00a0treatment of patients with inherited retinal dystrophies (IRDs) having severe vision loss. The broad designation from Saudi regulatory authorities further strengthens Nanoscope\u2019s expanding global regulatory footprint and reflects increasing international recognition of the company\u2019s proprietary Multi-Characteristic Opsin (MCO) platform as a potential first-in-class, disease-agnostic optogenetic therapy for vision restoration. \u201cMCO-010 development as a disease-agnostic optogenetic therapy continues to progress with regulatory [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":10078,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-10077","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-30T12:28:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-30T12:31:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Wilson PJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Wilson PJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/\"},\"author\":{\"name\":\"Wilson PJ\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/2fa4c7d9fcf90c2c01f1341935baf02d\"},\"headline\":\"Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration\",\"datePublished\":\"2026-03-30T12:28:13+00:00\",\"dateModified\":\"2026-03-30T12:31:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/\"},\"wordCount\":680,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_26_SaudiArabia_V3.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/\",\"name\":\"Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_26_SaudiArabia_V3.jpg\",\"datePublished\":\"2026-03-30T12:28:13+00:00\",\"dateModified\":\"2026-03-30T12:31:03+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_26_SaudiArabia_V3.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/NSCOPE_LI_26_SaudiArabia_V3.jpg\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2026\\\/03\\\/30\\\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/2fa4c7d9fcf90c2c01f1341935baf02d\",\"name\":\"Wilson PJ\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u3067MCO-010\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d6\u5f97\u3001\u8996\u529b\u56de\u5fa9\u5206\u91ce\u306b\u304a\u3051\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u898f\u5236\u5bfe\u5fdc\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3092\u62e1\u5927 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2026-03-30T12:28:13+00:00","article_modified_time":"2026-03-30T12:31:03+00:00","og_image":[{"width":1200,"height":242,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","type":"image\/jpeg"}],"author":"Wilson PJ","twitter_card":"summary_large_image","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Wilson PJ","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/"},"author":{"name":"Wilson PJ","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/2fa4c7d9fcf90c2c01f1341935baf02d"},"headline":"Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration","datePublished":"2026-03-30T12:28:13+00:00","dateModified":"2026-03-30T12:31:03+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/"},"wordCount":680,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_26_SaudiArabia_V3.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/","url":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u30b5\u30a6\u30b8\u30a2\u30e9\u30d3\u30a2\u3067MCO-010\u306e\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d6\u5f97\u3001\u8996\u529b\u56de\u5fa9\u5206\u91ce\u306b\u304a\u3051\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u898f\u5236\u5bfe\u5fdc\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3092\u62e1\u5927 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_26_SaudiArabia_V3.jpg","datePublished":"2026-03-30T12:28:13+00:00","dateModified":"2026-03-30T12:31:03+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_26_SaudiArabia_V3.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/NSCOPE_LI_26_SaudiArabia_V3.jpg","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2026\/03\/30\/nanoscope-therapeutics-receives-orphan-drug-designation-in-saudi-arabia-for-mco-010-expands-global-regulatory-leadership-in-vision-restoration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/2fa4c7d9fcf90c2c01f1341935baf02d","name":"\u30a6\u30a3\u30eb\u30bd\u30f3 PJ"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/10077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=10077"}],"version-history":[{"count":4,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/10077\/revisions"}],"predecessor-version":[{"id":10082,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/10077\/revisions\/10082"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/10078"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=10077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=10077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=10077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}